165 related articles for article (PubMed ID: 30645760)
21. Breast cancer incidence after hormonal infertility treatment in Sweden: a cohort study.
Orgéas CC; Sanner K; Hall P; Conner P; Holte J; Nilsson SJ; Sundfeldt K; Persson I; Chia KS; Wedren S; Dickman PW; Czene K
Am J Obstet Gynecol; 2009 Jan; 200(1):72.e1-7. PubMed ID: 19121659
[TBL] [Abstract][Full Text] [Related]
22. Effects of fertility drugs on cancers other than breast and gynecologic malignancies.
Brinton LA; Moghissi KS; Scoccia B; Lamb EJ; Trabert B; Niwa S; Ruggieri D; Westhoff CL
Fertil Steril; 2015 Oct; 104(4):980-988. PubMed ID: 26232746
[TBL] [Abstract][Full Text] [Related]
23. Risk of colorectal cancer after use of fertility drugs-results from a large Danish population-based cohort of women with infertility.
Møller M; Kjær SK; Lindquist S; Brown Frandsen CL; Albieri V; Viuff JH; Nøhr B; Olsen A; Jensen A
Fertil Steril; 2022 Oct; 118(4):738-747. PubMed ID: 36041966
[TBL] [Abstract][Full Text] [Related]
24. Breast cancer risk associated with ovulation-stimulating drugs.
Brinton LA; Scoccia B; Moghissi KS; Westhoff CL; Althuis MD; Mabie JE; Lamb EJ
Hum Reprod; 2004 Sep; 19(9):2005-13. PubMed ID: 15217997
[TBL] [Abstract][Full Text] [Related]
25. Women with alopecia exhibit a higher risk for thyroid cancer: a nationwide cohort study.
Sun LM; Lin MC; Muo CH; Liang JA; Sung FC; Kao CH
J Dermatol Sci; 2014 Apr; 74(1):18-22. PubMed ID: 24439037
[TBL] [Abstract][Full Text] [Related]
26. Risk of cancer after use of fertility drugs with in-vitro fertilisation.
Venn A; Watson L; Bruinsma F; Giles G; Healy D
Lancet; 1999 Nov; 354(9190):1586-90. PubMed ID: 10560672
[TBL] [Abstract][Full Text] [Related]
27. Thyroid cancer risk in women after hysterectomy: A nationwide cohort study.
Tai TS; Tsai CF; Yang HY
Maturitas; 2024 Jul; 185():107980. PubMed ID: 38555761
[TBL] [Abstract][Full Text] [Related]
28. Psychiatric disorders in women with fertility problems: results from a large Danish register-based cohort study.
Baldur-Felskov B; Kjaer SK; Albieri V; Steding-Jessen M; Kjaer T; Johansen C; Dalton SO; Jensen A
Hum Reprod; 2013 Mar; 28(3):683-90. PubMed ID: 23223399
[TBL] [Abstract][Full Text] [Related]
29. Progestin-primed milder stimulation with clomiphene citrate yields fewer oocytes and suboptimal pregnancy outcomes compared with the standard progestin-primed ovarian stimulation in infertile women with polycystic ovarian syndrome.
Ye H; Tian H; He W; Lyu Q; Kuang Y; Chen Q; Sun L
Reprod Biol Endocrinol; 2018 May; 16(1):53. PubMed ID: 29807533
[TBL] [Abstract][Full Text] [Related]
30. A randomized controlled trial of combination letrozole and clomiphene citrate or letrozole alone for ovulation induction in women with polycystic ovary syndrome.
Mejia RB; Summers KM; Kresowik JD; Van Voorhis BJ
Fertil Steril; 2019 Mar; 111(3):571-578.e1. PubMed ID: 30683591
[TBL] [Abstract][Full Text] [Related]
31. In situ and invasive cervical carcinoma in a cohort of infertile women.
Rossing MA; Daling JR; Weiss NS; Moore DE; Self SG
Fertil Steril; 1996 Jan; 65(1):19-22. PubMed ID: 8557140
[TBL] [Abstract][Full Text] [Related]
32. Use of fertility drugs and risk of ovarian cancer: results from a U.S.-based case-control study.
Kurta ML; Moysich KB; Weissfeld JL; Youk AO; Bunker CH; Edwards RP; Modugno F; Ness RB; Diergaarde B
Cancer Epidemiol Biomarkers Prev; 2012 Aug; 21(8):1282-92. PubMed ID: 22707710
[TBL] [Abstract][Full Text] [Related]
33. Breast cancer risk after exposure to fertility drugs.
Lo Russo G; Spinelli GP; Tomao S; Rossi B; Frati L; Panici PB; Vici P; Codacci Pisanelli G; Tomao F
Expert Rev Anticancer Ther; 2013 Feb; 13(2):149-57. PubMed ID: 23406556
[TBL] [Abstract][Full Text] [Related]
34. Assisted reproductive technology and the incidence of ovarian cancer: a meta-analysis.
Kashyap S; Moher D; Fung MF; Rosenwaks Z
Obstet Gynecol; 2004 Apr; 103(4):785-94. PubMed ID: 15051576
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the pregnancy outcomes and the incidence of fetal congenital abnormalities in infertile women treated with letrozole and clomiphene citrate.
Akbari Sene A; Ghorbani S; Ashrafi M
J Obstet Gynaecol Res; 2018 Jun; 44(6):1036-1041. PubMed ID: 29924470
[TBL] [Abstract][Full Text] [Related]
36. Use of fertility drugs and risk of ovarian cancer: Danish Population Based Cohort Study.
Jensen A; Sharif H; Frederiksen K; Kjaer SK
BMJ; 2009 Feb; 338():b249. PubMed ID: 19196744
[TBL] [Abstract][Full Text] [Related]
37. Breast and ovarian cancer incidence after infertility and in vitro fertilisation.
Venn A; Watson L; Lumley J; Giles G; King C; Healy D
Lancet; 1995 Oct; 346(8981):995-1000. PubMed ID: 7475593
[TBL] [Abstract][Full Text] [Related]
38. Risk of breast cancer after exposure to fertility drugs: results from a large Danish cohort study.
Jensen A; Sharif H; Svare EI; Frederiksen K; Kjaer SK
Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1400-7. PubMed ID: 17585058
[TBL] [Abstract][Full Text] [Related]
39. Type 1 diabetes impairs female fertility even before it is diagnosed.
Lin YH; Chen KJ; Peng YS; Chen PC; Yang YH
Diabetes Res Clin Pract; 2018 Sep; 143():151-158. PubMed ID: 30003941
[TBL] [Abstract][Full Text] [Related]
40. Comparison of treatment outcomes of infertile women by clomiphene citrate and letrozole with gonadotropins underwent intrauterine insemination.
Zadehmodares S; Niyakan M; Sharafy SA; Yazdi MH; Jahed F
Acta Med Iran; 2012; 50(1):18-20. PubMed ID: 22267373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
